Institutional investors purchased a net $177.6 thousand shares of MBOT during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 10.72% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 177.8 Thousand shares of Microbot Medical Inc
BLACKROCK FUND ADVISORS Bought 28.8 Thousand shares of Microbot Medical Inc
CITADEL ADVISORS LLC Bought 18.5 Thousand shares of Microbot Medical Inc